After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
GREENVILLE, S.C. (WSPA)– Infusion has long been a standard delivery method of chemotherapy for cancer patients. But, did you know that it’s also used to treat other conditions and diseases? We spoke ...
Reducing pembrolizumab infusions from 30 minutes to 10 minutes could be a safe alternative for patients and open hundreds of ...
Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, according to research ...
Regulatory T cells (Tregs) play a crucial role in maintaining a balanced immune system and safeguarding against chronic inflammatory diseases and autoimmune conditions. Scientists have long speculated ...
Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results